Lighthouse Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Lighthouse Investment Partners's BMY Position: Q1 2026 in Review
Lighthouse Investment Partners opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 42,245 shares worth $2.56M. The stake represents 0.09% of the portfolio and ranks #287 among its holdings. This is a return to the name: Lighthouse Investment Partners previously reported a position in BMY as recently as Q3 2024.
Lighthouse Investment Partners first reported a position in BMY in Q1 2024 and has held it in 4 quarters since. The position peaked at $5.91M in Q1 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Lighthouse Investment Partners held 42,245 shares of Bristol-Myers Squibb worth $2.56M as of Q1 2026.
- Bristol-Myers Squibb was a new Lighthouse Investment Partners position in Q1 2026.
- Bristol-Myers Squibb made up 0.09% of Lighthouse Investment Partners's portfolio in Q1 2026, its #287 holding.
- Lighthouse Investment Partners first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 4 quarters since.
- Lighthouse Investment Partners's Bristol-Myers Squibb position peaked at $5.91M in Q1 2024.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.